Ant International Highlights Democratising AI and Strengthening Trust in 2025 Sustainability Report
11.5.2026 11:17:00 CEST | Business Wire | Press Release
Ant International, a leading global digital payment, digitisation and financial technology provider, today published its 2025 Sustainability Report, the 2nd since the Company began independent operation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260511086227/en/
This is also the first year Ant International integrated sustainability metrics into the management's performance evaluation framework. As Eric Jing, Chairmanof Ant Group and Ant International said, “Accountability must be structural, not aspirational. When sustainability outcomes are valued as much as revenue growth or operational efficiency, the whole organisation is more likely to align accordingly-just like how it might work with entire economies.”
In the Company’s 6Ts Sustainability Framework (Travel, Trade, Thrive, Tech, Talent, Trust),Inclusion remains the critical objective. “Our success relies on our ability to innovate for small businesses and emerging markets to thrive above social and technological shifts. Doing great by doing good should be our strategic differentiator,” said Peng Yang, CEO and Douglas Feagin, President at the Report's launch.
- Alipay+ and Antom, the Company’s Global Payment pillars, now connect 2 bn user accounts globally to over 150 mn merchants. This vibrant ecosystem of interoperability links up more than 10 national QR systems and supports 300+ payment methods in over 220 markets, including all card schemes, and 50 digital wallets, bank apps and BNPL apps.
- Beyond payment, WorldFirst and Bettr, our Global Account and Embedded Finance services, support over 1.6 mn SMEs and provide credit access to 30 mn MSMEs and underserved users, integrating new AI and blockchain capabilities.
- The inclusion metric was built systemically into major innovation projects, for instance, more SME-friendly agentic payment and AI commerce tools, AI-as-a-Service platform for emerging markets, and the EPOS SME AI solutions.
“We will continue to double down on responsible innovation and collaboration to achieve our shared vision: a more inclusive, prosperous, and trustful global economy,” said Yang.
In 2025, Ant International’s sustainability work focused on 3 priorities across the 6T arenas:
1. Democratising FinAI for SMEs and Emerging Markets
Ant International rolled out various AI tools to ensure emerging markets and SMEs need to be able to leverage AI without massive infrastructure or capacity investments.
Payment AI & AgenticCommerce :
- Antom Copilot 2.0 completes payment integration, onboarding, risk and chargeback resolution in secure, automated workflow.
- Antom Agentic Payment Solution enables AI agents to securely initiate and complete card- and APM-based transactions in a pioneering payment mandate model.
FinAI Capacity Building:
- FinAI-as-a-Service platform, the GenAI Cockpit gives toolkits to fintechs, such as Malaysia's TNG eWallet, and easypaisa, Pakistan’s first digital bank, to build flexible and autonomous AI commerce solutions, from customer-service assistants to sales copilots.
- Custom-made agentic AI assistants such as Alipay+ Voyager, an agentic AI travel companion embedded in super apps.
- Open-sourced AI FX solution delivers FX forecasts with up to 93% prediction accuracy across complex, volatile currency markets.
- EPOS360, an AI-powered SME operation and financing platform, rolls out in Southeast Asia.
2. Enhancing Compliance and Technology Foundations of Trust
The Company invested heavily in 2025 on technologies and partnerships on AML and security.
- SHIELD 3-in-1 Transformer model, supported by 7 bn parameters, identifies high-risk transactions with over 95% precision, while raising payment success rates by up to 13.5%.
- Digital Wallet Guardian Partnership shares risk tech, anti-fraud and funds protection solutions among wallet partners to protect consumers and merchants.
- The Alipay+ Privacy Enhancing Technology (PET) programme was cited by Singapore's Personal Data Protection Commission in its practical guidance for industry application.
Meanwhile, advanced technology application must be harnessed by rigorous compliance standards and practices. In 2025, we further expanded:
- Our Risk Management Committee mechanism, which implements a comprehensive risk governance framework from the corporate down to the ground unit level.
- Our 3-layered Anti-Money-Laundering programme is anchored in a global baseline of minimum control standards to ensure consistency and integrity across all markets. We also use AI-powered risk detection and security review tools to improve accuracy and efficiency.
The Company plans to accelerate investments in global and local compliance capabilities to meet evolving regulatory and risk environments.
3. Digitalising Public Participation to Drive Social Impact
In 2025, working with partners from New York to West Java, our people started new grassroots efforts to support youth, environment and community projects with digital expertise.
- As the Innovation Partner for Sustainability of the New York Liberty, Alipay+ began supportingNew York Liberty, the WNBA champion team on Liberty Sneaker Drives for underprivileged groups, Math Hoops project to build youth skills, and Threes for Trees project in NYC and Brooklyn.
- AlipayHK launched a main digital channel for charity fundraising after the Tai Po fire, raising HK$200 million from 450,000 super app users in first three days.
- Ocean Buddy, an in-app mini-programme for whale-shark protection in Indonesia, was launched in collaboration with DANA and Konservasi Indonesia, leveraging gamification to connect users’ everyday digital activities to marine protection.
- 10x1000 Tech for Inclusion, a joint initiative with the International Finance Corporation (IFC) and over 50 global partners, has certified 9,504 since 2018, 55% of whom are women.
“Sustainability is increasingly becoming our primary driver of responsible innovation, “said Leiming Chen, Chief Sustainability Officer of Ant International, “we will work together to ensure that as we expand globally, our progress remains inclusive, measurable, and impactful for the communities we serve.”
Find the full Report on our website: www.ant-intl.com
About Ant International
Ant International is a leading global digital payment, digitisation and financial technology provider. Through collaboration across the private and public sectors, our unified techfin platform supports financial institutions and merchants of all sizes to achieve inclusive growth through a comprehensive range of cutting-edge digital payment and financial services solutions. To learn more, please visit https://www.ant-intl.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20260511086227/en/
Contacts
For media enquiries, please contact
Ant International Global Communications
pr@ant-intl.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press Release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press Release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press Release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom